RELAXaHEAD App for Migraine
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two versions of a smartphone app called RELAXaHEAD, designed to help people manage migraines. The study will evaluate the app's effectiveness in reducing headaches and improving quality of life. Individuals who have experienced migraines for at least a year and have between 4 to 29 headache days a month may qualify. Participants will use one version of the app, which includes self-management tools with written and audio materials. As an unphased trial, participants contribute to innovative research that may enhance migraine management for many.
Will I have to stop taking my current medications?
The trial requires that you do not change your preventive medications for 3 months before starting and during the 6 weeks of the study. This means you should continue taking your current preventive medications without changes.
What prior data suggests that the RELAXaHEAD app is safe for migraine management?
Research has shown that the RELAXaHEAD Smartphone App, designed for managing migraines, is generally safe for use. Studies have found that the app's progressive muscle relaxation (PMR) feature is well-tolerated, with most users not experiencing negative effects.
One study found that the app reduced the impact of migraines, helping users manage their symptoms more effectively. Reports of serious side effects have not emerged, indicating the app's safety for migraine management. Both versions of the app focus on PMR, which has already been proven safe and effective in preventing migraines.
Overall, users can expect a safe experience with the app and may find relief from their migraines.12345Why are researchers excited about this trial?
Researchers are excited about the RELAXaHEAD app because it offers a fresh approach to migraine self-management through technology. Unlike traditional migraine treatments that often involve medications like triptans or preventative drugs, the RELAXaHEAD app empowers users with digital tools to manage their migraines. Version 1 provides written materials for self-management, while Version 2 enhances this with audio resources, which can make the self-care process more engaging and personalized. This innovative use of smartphone technology could make migraine management more accessible and convenient for many people, potentially reducing reliance on medication alone.
What evidence suggests that the RELAXaHEAD app is effective for migraine?
Research has shown that the RELAXaHEAD app, which uses progressive muscle relaxation (PMR), may help people with migraines. Studies have found that this app can noticeably reduce migraine-related difficulties, leading to small to moderate improvement. Users might find it easier to manage daily tasks even during migraines. Designed for smartphones, the app offers a convenient way to manage migraines independently. In this trial, participants will receive either version 1 or version 2 of the app, both designed to provide tools to lessen the impact of migraines.12346
Who Is on the Research Team?
Mia T Minen, MD
Principal Investigator
NYU Langone Health
Are You a Good Fit for This Trial?
This trial is for English-speaking individuals aged 16 or older who have been experiencing migraines for at least a year and have had a stable pattern of headaches ranging from 4-29 days per month. They must not plan to change their preventive medication during the study and should have a reduced quality of life due to migraines. People with recent relaxation therapy, substance abuse issues, severe depression, medication overuse headache, or those without access to a smartphone cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the RELAXaHEAD app intervention for migraine self-management between baseline and weeks 3-6
Follow-up
Participants are monitored for persistence of effects up to 26 weeks post-treatment
What Are the Treatments Tested in This Trial?
Interventions
- RELAXaHEAD Smartphone App Version 1
- RELAXaHEAD Smartphone App Version 2
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor
National Institutes of Health (NIH)
Collaborator